Canada’s five federally supported biomanufacturing research hubs are now developing novel vaccines and other therapeutics, building new specialized facilities, and establishing programs to train the next generation of researchers to be “pandemic ready.” The hubs aim to close critical gaps in the domestic life sciences pipeline, ensuring Canada can rapidly manufacture life-saving therapeutics during future health emergencies.